GBA1 and Parkinson disease: It is now known that (heterozygous) mutations in GBA are the most common genetic risk factor for Parkinson’s disease [12], which has had a huge impact on the study of sphingolipid synthesis and degradation, and how the pathways of degradation are regulated.